Amylyx Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC AMLX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

712,990

Value ($000)

8,613

Weight

0.0%

2022 Q1 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	8,613	0.0%	712,990	12/31/2025
2025 Q3	11/10/2025	8,768	0.0%	645,185	9/30/2025
2025 Q2	8/12/2025	3,772	0.0%	588,411	6/30/2025
2025 Q1	9/15/2025	1,320	0.0%	372,853	3/31/2025
2024 Q4	2/6/2025	1,130	0.0%	298,949	12/31/2024
2024 Q3	11/12/2024	979	0.0%	302,270	9/30/2024
2024 Q2	8/12/2024	991	0.0%	521,619	6/30/2024
2024 Q1	5/9/2024	1,238	0.0%	435,903	3/31/2024
2023 Q4	2/6/2024	5,706	0.0%	387,620	12/31/2023
2023 Q3	11/8/2023	6,699	0.0%	365,862	9/30/2023
2023 Q2	8/10/2023	7,021	0.0%	325,482	6/30/2023
2023 Q1	5/12/2023	9,391	0.0%	320,086	3/31/2023
2022 Q4	2/13/2023	11,740	0.0%	317,719	12/31/2022
2022 Q3	11/14/2022	6,777	0.0%	240,739	9/30/2022
2022 Q2	8/15/2022	1,357	0.0%	70,409	6/30/2022
2022 Q1	5/13/2022	939	0.0%	73,027	3/31/2022